Gelonghui announced that the company recently received an invention patent certificate issued by the State intellectual property Office under the name of taxane compounds and their pharmaceutical compositions and uses. 688566.SH announced that the company recently received an invention patent certificate issued by the State intellectual property Office.
The above invention patent is the compound patent of the company authorized by the State intellectual property Office in the research and development of new antineoplastic drug (JJH201601).
The acquisition of the above invention patent is the embodiment and extension of the company's core technology, and the acquisition of this invention patent will not have a significant impact on the company's recent operation, but will help to further improve the company's intellectual property protection system, give full play to the technological advantages of independent intellectual property rights, and promote technological innovation, so as to enhance the company's core competitiveness.